Inhaled Mometasone to Promote Reduction in Vasoocclusive Events 2
Condition(s):Sickle Cell DiseaseLast Updated:June 18, 2023Completed
Hide Studies Not Open or Pending
Condition(s):Sickle Cell DiseaseLast Updated:June 18, 2023Completed
Condition(s):Sickle Cell DiseaseLast Updated:December 11, 2019Completed
Condition(s):Blood Disease; Cerebrovascular Accident; Anemia, Sickle CellLast Updated:February 18, 2016Completed
Condition(s):Sickle Cell Disease; Beta Thalassemia-MajorLast Updated:August 24, 2021Completed
Condition(s):Sickle Cell DiseaseLast Updated:May 3, 2023Completed
Condition(s):Sickle Cell Disease; Acute Chest SyndromeLast Updated:September 26, 2018Completed
Condition(s):Sickle Cell DiseaseLast Updated:February 26, 2024Recruiting
Condition(s):Anemia, Sickle CellLast Updated:February 15, 2012Completed
Condition(s):Pulmonary HypertensionLast Updated:September 25, 2019Completed
Condition(s):Sickle Cell DiseaseLast Updated:September 14, 2023Withdrawn
At TrialBulletin.com, we keep tabs on over 200,000 clinical trials in the US and abroad, using medical data supplied directly by the US National Institutes of Health. Please see the About and Contact page for details.